The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...

The RSV vaccination eligibility age has been lowered from 60 years to 50 years according to an update on the CDC website.

Robert F. Kennedy Jr. had fired all 17 members of a key vaccine panel. Now his new panel recommended a new infant RSV vaccine ...

The votes on vaccine recommendations are the first move by the panel after Health and Human Services Secretary Robert F.

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following ...

The US FDA approved an RSV vaccine called Arexvy. How effective is it, when will it be available, and who can take it? CNN Medical Analyst Dr. Leana Wen explains.

The Food and Drug Administration on Wednesday approved Arexvy, the world's first respiratory syncytial virus (RSV) vaccine — a scientific breakthrough 60 years in the making.

A Pfizer vaccine to protect older adults and infants from respiratory syncytial virus (RSV) infection has shown what some scientists are calling “exciting” promise in late-stage trials.

There are shortages of an RSV vaccine for infants due to supply issues. The Centers for Disease Control and Prevention (CDC) released a notice last week citing "limited availability" of the long ...

With the 2025 influenza season starting earlier than usual, the NICD urges South Africans to stay vigilant against seasonal viruses like flu and RSV. Learn about the symptoms, preventive measures, and ...

It’s unclear whether the maternal RSV vaccine, Abrysvo, will be available in time to protect infants born during the upcoming RSV season, which usually starts in fall and peaks in winter.

RSV vaccines by Pfizer and GlaxoSmithKline for people aged 60 years and older were approved by the FDA earlier this year and have shown to be up to 94% effective at preventing severe illness.